Q13428 (TCOF_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 121.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Treacle protein Alternative name(s): Treacher Collins syndrome protein | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1488 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May be involved in nucleolar-cytoplasmic transport. May play a fundamental role in early embryonic development, particularly in development of the craniofacial complex By similarity. May participate in certain stages of ribosome biogenesis. Ref.8 |
| Subunit structure | Part of a large pre-ribosomal ribonucleoprotein (RNP) complex, that consists of at least 62 ribosomal proteins, 45 nonribosomal proteins and both pre-rRNA and mature rRNA species. Within this complex directly interacts with NOP56 in an RNA-independent manner. Ref.8 |
| Subcellular location | |
| Involvement in disease | Treacher Collins syndrome 1 (TCS1) [MIM:154500]: A form of Treacher Collins syndrome, a disorder of craniofacial development. Treacher Collins syndrome is characterized by a combination of bilateral downward slanting of the palpebral fissures, colobomas of the lower eyelids with a paucity of eyelashes medial to the defect, hypoplasia of the facial bones, cleft palate, malformation of the external ears, atresia of the external auditory canals, and bilateral conductive hearing loss. |
| Sequence similarities | Contains 1 LisH domain. |
| Sequence caution | The sequence AAH16144.1 differs from that shown. Reason: Contaminating sequence. Potential poly-A sequence. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Transport |
| Cellular component | Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Disease | Disease mutation |
| PTM | Acetylation Phosphoprotein |
| Technical term | Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | skeletal system development Traceable author statement Ref.3. Source: ProtInc transcription of nuclear large rRNA transcript from RNA polymerase I promoterInferred from electronic annotation. Source: Compara |
| Cellular_component | cytoplasm Inferred from direct assay. Source: HPA nucleolusInferred from direct assay. Source: HPA |
| Molecular_function | transporter activity Traceable author statement Ref.3. Source: ProtInc |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| ARRB1 | P49407 | 3 | EBI-396105,EBI-743313 | |
| ARRB2 | P32121 | 3 | EBI-396105,EBI-714559 |
Alternative products
| This entry describes 8 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q13428-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Note: Major. | ||||||
| Isoform 2 (identifier: Q13428-2) The sequence of this isoform differs from the canonical sequence as follows: 214-290: Missing. | ||||||
| Isoform 3 (identifier: Q13428-3) The sequence of this isoform differs from the canonical sequence as follows: 1172-1172: L → LV | ||||||
| Isoform 4 (identifier: Q13428-4) The sequence of this isoform differs from the canonical sequence as follows: 953-953: Q → QDSNSKPARSKTLAPAPPERNTEGSSESSEEELPLTQ | ||||||
| Note: Minor. | ||||||
| Isoform 5 (identifier: Q13428-5) The sequence of this isoform differs from the canonical sequence as follows: 954-958: VIKPP → DQESS 959-1488: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 6 (identifier: Q13428-6) The sequence of this isoform differs from the canonical sequence as follows: 1062-1099: Missing. | ||||||
| Isoform 7 (identifier: Q13428-7) The sequence of this isoform differs from the canonical sequence as follows: 1062-1099: Missing. 1172-1172: L → LV | ||||||
| Isoform 8 (identifier: Q13428-8) The sequence of this isoform differs from the canonical sequence as follows: 214-290: Missing. 1172-1172: L → LV | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1488 | 1488 | Treacle protein | PRO_0000072459 | |||||
Regions | |||||||||
| Domain | 6 – 38 | 33 | LisH | ||||||
| Compositional bias | 89 – 97 | 9 | Poly-Glu | ||||||
| Compositional bias | 204 – 207 | 4 | Poly-Ser | ||||||
| Compositional bias | 693 – 696 | 4 | Poly-Ser | ||||||
| Compositional bias | 996 – 1001 | 6 | Poly-Ser | ||||||
| Compositional bias | 1362 – 1366 | 5 | Poly-Lys | ||||||
| Compositional bias | 1452 – 1463 | 12 | Poly-Lys | ||||||
| Compositional bias | 1475 – 1482 | 8 | Poly-Lys | ||||||
Amino acid modifications | |||||||||
| Modified residue | 83 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 84 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 85 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 87 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 88 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 153 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 155 | 1 | N6-acetyllysine Ref.18 | ||||||
| Modified residue | 156 | 1 | Phosphoserine Ref.15 Ref.17 Ref.19 Ref.21 | ||||||
| Modified residue | 171 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 173 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 233 | 1 | Phosphoserine Ref.19 Ref.21 | ||||||
| Modified residue | 249 | 1 | Phosphothreonine Ref.10 Ref.17 Ref.19 | ||||||
| Modified residue | 296 | 1 | N6-acetyllysine Ref.18 | ||||||
| Modified residue | 310 | 1 | Phosphothreonine Ref.15 Ref.19 | ||||||
| Modified residue | 316 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 339 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 342 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 343 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 347 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 349 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 381 | 1 | Phosphoserine Ref.9 Ref.11 Ref.15 Ref.17 Ref.19 Ref.21 | ||||||
| Modified residue | 413 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 414 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 417 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 419 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 430 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 446 | 1 | Phosphoserine Ref.9 Ref.11 Ref.19 Ref.21 | ||||||
| Modified residue | 503 | 1 | Phosphoserine Ref.15 Ref.19 Ref.21 | ||||||
| Modified residue | 545 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 547 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 548 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 549 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 581 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 583 | 1 | Phosphoserine Ref.15 Ref.17 Ref.19 Ref.21 | ||||||
| Modified residue | 600 | 1 | N6-acetyllysine Ref.18 | ||||||
| Modified residue | 608 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 610 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 611 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 614 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 615 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 620 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 679 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 686 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 693 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 694 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 695 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 755 | 1 | N6-acetyllysine Ref.18 | ||||||
| Modified residue | 762 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 764 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 765 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 769 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 771 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 777 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 868 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 870 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 871 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 875 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 877 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 906 | 1 | Phosphoserine Ref.9 Ref.11 Ref.13 Ref.14 Ref.19 Ref.21 | ||||||
| Modified residue | 914 | 1 | Phosphothreonine Ref.11 Ref.19 | ||||||
| Modified residue | 967 | 1 | Phosphoserine Ref.13 Ref.21 | ||||||
| Modified residue | 983 | 1 | Phosphothreonine Ref.17 | ||||||
| Modified residue | 998 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1111 | 1 | Phosphoserine Ref.10 Ref.15 Ref.17 | ||||||
| Modified residue | 1149 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 1150 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 1153 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 1154 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 1190 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1228 | 1 | Phosphoserine Ref.10 Ref.15 Ref.17 Ref.21 | ||||||
| Modified residue | 1234 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 1257 | 1 | Phosphoserine Ref.9 Ref.15 Ref.19 Ref.21 | ||||||
| Modified residue | 1350 | 1 | Phosphoserine Ref.9 Ref.14 Ref.19 Ref.21 | ||||||
| Modified residue | 1376 | 1 | Phosphoserine Ref.15 Ref.17 Ref.21 | ||||||
| Modified residue | 1378 | 1 | Phosphoserine Ref.10 Ref.15 Ref.17 Ref.19 Ref.21 | ||||||
| Modified residue | 1407 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 1410 | 1 | Phosphoserine Ref.15 Ref.19 | ||||||
| Modified residue | 1414 | 1 | N6-acetyllysine Ref.18 | ||||||
Natural variations | |||||||||
| Alternative sequence | 214 – 290 | 77 | Missing in isoform 2 and isoform 8. | VSP_022295 | |||||
| Alternative sequence | 953 | 1 | Q → QDSNSKPARSKTLAPAPPER NTEGSSESSEEELPLTQ in isoform 4. | VSP_022296 | |||||
| Alternative sequence | 954 – 958 | 5 | VIKPP → DQESS in isoform 5. | VSP_023133 | |||||
| Alternative sequence | 959 – 1488 | 530 | Missing in isoform 5. | VSP_023134 | |||||
| Alternative sequence | 1062 – 1099 | 38 | Missing in isoform 6 and isoform 7. | VSP_040382 | |||||
| Alternative sequence | 1172 | 1 | L → LV in isoform 3, isoform 7 and isoform 8. | VSP_022297 | |||||
| Natural variant | 53 | 1 | W → R in TCS1. Ref.22 | VAR_005630 | |||||
| Natural variant | 221 | 1 | A → P. Corresponds to variant rs11541811 [ dbSNP | Ensembl ]. | VAR_057002 | |||||
| Natural variant | 516 | 1 | P → L. Ref.22 | VAR_005631 | |||||
| Natural variant | 665 | 1 | A → P. Ref.1 Ref.2 Ref.3 Ref.4 Corresponds to variant rs2071240 [ dbSNP | Ensembl ]. | VAR_029869 | |||||
| Natural variant | 887 | 1 | V → A. Ref.1 Ref.2 Ref.3 Ref.4 Ref.7 Ref.22 Corresponds to variant rs7713638 [ dbSNP | Ensembl ]. | VAR_005632 | |||||
| Natural variant | 1030 | 1 | R → K in a colorectal cancer sample; somatic mutation. Ref.23 | VAR_035666 | |||||
| Natural variant | 1176 | 1 | P → R. Corresponds to variant rs1136103 [ dbSNP | Ensembl ]. | VAR_059729 | |||||
| Natural variant | 1280 | 1 | G → R. Corresponds to variant rs11541812 [ dbSNP | Ensembl ]. | VAR_059730 | |||||
| Natural variant | 1390 | 1 | A → V. Ref.22 Corresponds to variant rs15251 [ dbSNP | Ensembl ]. | VAR_005633 | |||||
| Natural variant | 1431 | 1 | G → A. Corresponds to variant rs45491898 [ dbSNP | Ensembl ]. | VAR_061709 | |||||
| Natural variant | 1432 | 1 | D → G. Ref.22 | VAR_005634 | |||||
Experimental info | |||||||||
| Sequence conflict | 1271 | 1 | P → L in BAG64623. Ref.7 | ||||||
| Sequence conflict | 1389 | 1 | K → Q in AAB40722. Ref.2 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome." Dixon J., Edwards S.J., Gladwin A.J., Dixon M.J., Loftus S.K., Bonner C.A., Koprivnikar K., Wasmuth J.J. Nat. Genet. 12:130-136(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), VARIANTS PRO-665 AND ALA-887. |
| [2] | "Identification of the complete coding sequence and genomic organization of the Treacher Collins syndrome gene." Dixon J., Edwards S.J., Anderson I., Brass A., Scambler P.J., Dixon M.J. Genome Res. 7:223-234(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), VARIANTS PRO-665 AND ALA-887. |
| [3] | "TCOF1 gene encodes a putative nucleolar phosphoprotein that exhibits mutations in Treacher Collins syndrome throughout its coding region." Wise C.A., Chiang L.C., Paznekas W.A., Sharma M., Musy M.M., Ashley J.A., Lovett M., Jabs E.W. Proc. Natl. Acad. Sci. U.S.A. 94:3110-3115(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], VARIANTS PRO-665 AND ALA-887. |
| [4] | "Another face of the Treacher Collins syndrome (TCOF1) gene: identification of additional exons." So R.B., Gonzales B., Henning D., Dixon J., Dixon M.J., Valdez B.C. Gene 328:49-57(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING (ISOFORM 4), VARIANTS PRO-665 AND ALA-887. |
| [5] | "The DNA sequence and comparative analysis of human chromosome 5." Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S. Rubin E.M.Nature 431:268-274(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1448 (ISOFORM 6), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 16-1188 (ISOFORM 3). Tissue: Eye and Skin. |
| [7] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1452 (ISOFORM 7), VARIANT ALA-887. Tissue: Thymus. |
| [8] | "Proteomic analysis of human Nop56p-associated pre-ribosomal ribonucleoprotein complexes. Possible link between Nop56p and the nucleolar protein treacle responsible for Treacher Collins syndrome." Hayano T., Yanagida M., Yamauchi Y., Shinkawa T., Isobe T., Takahashi N. J. Biol. Chem. 278:34309-34319(2003) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 63-74; 101-122; 135-155; 297-308; 368-379; 433-444; 503-519; 571-586; 706-716; 733-755; 792-803; 893-904; 1065-1078; 1130-1138; 1225-1238; 1245-1259; 1318-1329 AND 1424-1437, FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION IN A PRE-RIBOSOMAL RNP COMPLEX, INTERACTION WITH NOP56, MASS SPECTROMETRY. |
| [9] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-381; SER-446; SER-620; SER-906; SER-1257 AND SER-1350, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-249; SER-1111; SER-1228 AND SER-1378, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-381; SER-446; SER-906 AND THR-914, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Embryonic kidney. |
| [13] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-906 AND SER-967, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-906 AND SER-1350, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; THR-84; SER-85; SER-87; SER-88; SER-153; SER-156; THR-310; THR-316; SER-381; SER-503; THR-581; SER-583; SER-762; SER-764; SER-765; SER-769; SER-771; SER-777; SER-868; SER-870; SER-871; SER-875; SER-877; SER-998; SER-1111; SER-1190; SER-1228; THR-1234; SER-1257; SER-1376; SER-1378; SER-1407 AND SER-1410, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [17] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; THR-249; SER-381; SER-583; THR-983; SER-1111; SER-1228; SER-1376 AND SER-1378, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [18] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-155; LYS-296; LYS-600; LYS-755 AND LYS-1414, MASS SPECTROMETRY. |
| [19] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; SER-233; THR-249; THR-310; SER-381; SER-446; SER-503; SER-583; SER-868; SER-870; SER-871; SER-875; SER-877; SER-906; THR-914; SER-1257; SER-1350; SER-1378 AND SER-1410, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [20] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [21] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; SER-233; SER-381; SER-446; SER-503; SER-583; SER-906; SER-967; SER-1228; SER-1257; SER-1350; SER-1376 AND SER-1378, MASS SPECTROMETRY. |
| [22] | "The mutational spectrum in Treacher Collins syndrome reveals a predominance of mutations that create a premature-termination codon." Edwards S.J., Gladwin A.J., Dixon M.J. Am. J. Hum. Genet. 60:515-524(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS LEU-516; ALA-887; VAL-1390 AND GLY-1432, VARIANT TCS1 ARG-53. |
| [23] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] LYS-1030. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U40847 mRNA. Translation: AAC50903.1. U76366 mRNA. Translation: AAC51181.1. U84664 U84663 Genomic DNA. Translation: AAC51185.1.U79659 U79658 Genomic DNA. Translation: AAB40722.1.AY460334 mRNA. Translation: AAR87774.1. AC011372 Genomic DNA. No translation available. BC011764 mRNA. Translation: AAH11764.1. BC014559 mRNA. Translation: AAH14559.1. BC016144 mRNA. Translation: AAH16144.1. Sequence problems. BC027252 mRNA. Translation: AAH27252.1. BC033093 mRNA. Translation: AAH33093.1. AK303611 mRNA. Translation: BAG64623.1. |
| IPI | IPI00165041. IPI00298696. IPI00555853. IPI00815713. IPI00815731. IPI00815944. IPI00914061. IPI00969501. |
| RefSeq | NP_000347.2. NM_000356.3. NP_001008657.1. NM_001008657.2. NP_001128715.1. NM_001135243.1. NP_001128716.1. NM_001135244.1. NP_001128717.1. NM_001135245.1. NP_001182070.1. NM_001195141.1. |
| UniGene | Hs.519672. Hs.605019. |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q13428. 14 interactions. |
| STRING | 9606.ENSP00000406888. |
PTM databases | |
| PhosphoSite | Q13428. |
Polymorphism databases | |
| DMDM | 302393806. |
Proteomic databases | |
| PaxDb | Q13428. |
| PRIDE | Q13428. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000323668; ENSP00000325223; ENSG00000070814. ENST00000377797; ENSP00000367028; ENSG00000070814. ENST00000394269; ENSP00000377811; ENSG00000070814. ENST00000439160; ENSP00000406888; ENSG00000070814. ENST00000445265; ENSP00000409944; ENSG00000070814. ENST00000504761; ENSP00000421655; ENSG00000070814. |
| GeneID | 6949. |
| KEGG | hsa:6949. |
| UCSC | uc003lrw.3. human. uc003lrx.3. human. uc003lry.3. human. uc003lrz.3. human. uc003lsa.3. human. uc011dch.2. human. |
Organism-specific databases | |
| CTD | 6949. |
| GeneCards | GC05P149717. |
| H-InvDB | HIX0005313. |
| HGNC | HGNC:11654. TCOF1. |
| HPA | CAB033199. HPA038237. HPA038238. |
| MIM | 154500. phenotype. 606847. gene. |
| neXtProt | NX_Q13428. |
| Orphanet | 861. Treacher-Collins syndrome. |
| PharmGKB | PA36405. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG12793. |
| HOVERGEN | HBG006664. |
| InParanoid | Q13428. |
| KO | K14562. |
Gene expression databases | |
| ArrayExpress | Q13428. |
| Bgee | Q13428. |
| CleanEx | HS_TCOF1. |
| Genevestigator | Q13428. |
| GermOnline | ENSG00000070814. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR006594. LisH_dimerisation. IPR003993. TCS_treacle. IPR017859. Treacle-like_TCS. [Graphical view] |
| Pfam | PF03546. Treacle. 6 hits. [Graphical view] |
| PRINTS | PR01503. TREACLE. |
| SMART | SM00667. LisH. 1 hit. [Graphical view] |
| PROSITE | PS50896. LISH. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | TCOF1. human. |
| GenomeRNAi | 6949. |
| NextBio | 27207. |
| PMAP-CutDB | Q13428. |
| SOURCE | Search... |
Entry information
| Entry name | TCOF_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q13428 Secondary accession number(s): A0JLU0 Q99860 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
